Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Another Change At Perrigo Helm As Results Remain Turbulent

Executive Summary

Incoming CEO Murray Kessler is a seasoned veteran of regulated consumer markets – but not health care. Will his combination of experience and fresh perspective help enable the OTC private label market leader to reverse share declines?


Related Content

Perrigo Expanding Consumer Portfolio After Finding Problems Slowing Growth
Perrigo Pivots To 'Self Care' For 'Massive Opportunity' Beyond OTC Drugs
Perrigo's OTC Priority Shows In Launch Of Imodium Multi-Symptom Equivalent
Perrigo's OTC Core Could Expand To Include National Brands
Rulemaking For OTC Switch Process Changes Pushed To 2019
Perrigo Taps CEO With Global Operations Expertise At Pharma Packaging Firm
Amazon OTCs Likely A Worry For Retailers, A Remedy For Perrigo
Deal Watch: WuXi/Gloria License PD-1 Inhibitor To Arcus For Up To $816m
Perrigo CEO Takes Faith In Rx Generics Business To Exit Door With Him
Perrigo Trims Workforce, Ships Tysabri License, Stays European Course


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts